SICKLE CELL DISEASE | Limited Progress in Sickle Cell Disease Highlights Barriers to Treatment Access – TIF
According to the findings, there has been limited improvement in outcomes for SCD patients, in large| TIF
Each booklet focuses on a specific aspect of the updated guidelines for transfusion-dependent thalassaemia (TDT), non-transfusion-dependent β-thalassaemia (NTDT), and α-thalassaemia, allowing physicians from various specialties to access critical, evidence-based recommendations …| TIF
SCD is a genetic disorder in which red blood cells can become abnormally shaped (“sickle”), leading to blockages in blood vessels, tissue damage, and intense pain known as vaso-occlusive events …| TIF
According to the findings, there has been limited improvement in outcomes for SCD patients, in large| TIF
Fentanyl is a powerful painkiller that has already been widely used in children with SCD and in adults with cancer or chronic pain. Researchers now believe its use in adults …| TIF
Nurses are the heart of haemoglobinopathy care. Their role spans far beyond routine tasks—encompassing complex clinical duties, patient advocacy, case management, emotional and psychosocial support, and education of both patients …| TIF
Why This Matters High maternal risk: Pregnant women with SCD face a 4–11× greater risk of mat| TIF
Condition| Pediatrics Nationwide
For people with sickle cell disease who menstruate, hormonal contraception can be effective against SCD-related pain, but it also raises the risk of thrombosis. | Pediatrics Nationwide
Recent research shows that a commonly inherited polymorphism could impact outcomes.| Pediatrics Nationwide
Using the safe and sensible CRISPR technology that has the power to help the 300,000 babies born with sickle cell disease each year and the nearly 10 million people estimated to suffer from this genetic disorder globally.| science.thewire.in
